Fulcrum Therapeutics, Inc. (FULC) vs Larimar Therapeutics, Inc. (LRMR)
A side-by-side comparison of Fulcrum Therapeutics, Inc. and Larimar Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
FULC
Fulcrum Therapeutics, Inc.
$3.69HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
LRMR
Larimar Therapeutics, Inc.
$2.78HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — FULC vs LRMR
growth of $100 · dividends reinvested · last 7yFULC -72.5% (-16.8%/yr)LRMR -79.5% (-20.2%/yr)FULC compounded faster over this window
FULC LRMR
FULC vs LRMR: by the numbers
- •LRMR is the larger company ($289M vs $282M market cap).
Metrics side by side
Valuation
| Metric | FULC | LRMR |
|---|---|---|
| P/B ratio | 0.91 | 2.27 |
Profitability
| Metric | FULC | LRMR |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -27.36% | -135.50% |
| ROIC | -27.62% | -136.49% |
Growth (annualized)
| Metric | FULC | LRMR |
|---|---|---|
| Total return CAGR (5Y) | -31.70% | -23.91% |
Frequently asked
- How have FULC and LRMR total returns compared?
- Over the past 5 years, FULC delivered -31.70% and LRMR delivered -23.91% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.